IL78571A - Human tissue plasminogen activator mutants resistant to enzymatic cleavage resulting in two-chain form - Google Patents
Human tissue plasminogen activator mutants resistant to enzymatic cleavage resulting in two-chain formInfo
- Publication number
- IL78571A IL78571A IL78571A IL7857186A IL78571A IL 78571 A IL78571 A IL 78571A IL 78571 A IL78571 A IL 78571A IL 7857186 A IL7857186 A IL 7857186A IL 78571 A IL78571 A IL 78571A
- Authority
- IL
- Israel
- Prior art keywords
- plasminogen activator
- human tissue
- tissue plasminogen
- vectors
- enzymatic cleavage
- Prior art date
Links
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 title abstract 4
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 title abstract 3
- 238000003776 cleavage reaction Methods 0.000 title abstract 3
- 230000007017 scission Effects 0.000 title abstract 3
- 229960000187 tissue plasminogen activator Drugs 0.000 title abstract 3
- 230000002255 enzymatic effect Effects 0.000 title abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 2
- 239000013604 expression vector Substances 0.000 abstract 2
- 239000013598 vector Substances 0.000 abstract 2
- 241000699802 Cricetulus griseus Species 0.000 abstract 1
- 241000588724 Escherichia coli Species 0.000 abstract 1
- 108091034117 Oligonucleotide Proteins 0.000 abstract 1
- 241000724220 Phage M13mp8 Species 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 238000004113 cell culture Methods 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 210000001672 ovary Anatomy 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
- 238000002741 site-directed mutagenesis Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
- C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
- C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72546885A | 1985-04-22 | 1985-04-22 | |
| US84669786A | 1986-04-01 | 1986-04-01 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL78571A0 IL78571A0 (en) | 1986-08-31 |
| IL78571A true IL78571A (en) | 1991-06-30 |
Family
ID=27111150
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL78571A IL78571A (en) | 1985-04-22 | 1986-04-21 | Human tissue plasminogen activator mutants resistant to enzymatic cleavage resulting in two-chain form |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5147643A (de) |
| EP (1) | EP0199574B1 (de) |
| JP (2) | JPH0740940B2 (de) |
| AT (1) | ATE68825T1 (de) |
| AU (1) | AU596356B2 (de) |
| CA (1) | CA1341580C (de) |
| DD (1) | DD258026A5 (de) |
| DE (2) | DE3682104D1 (de) |
| DK (1) | DK175380B1 (de) |
| ES (2) | ES8802184A1 (de) |
| FI (1) | FI98930C (de) |
| FR (1) | FR2581652B1 (de) |
| GB (1) | GB2173804B (de) |
| GR (1) | GR861037B (de) |
| HU (1) | HU206520B (de) |
| IE (1) | IE58574B1 (de) |
| IL (1) | IL78571A (de) |
| MY (1) | MY102550A (de) |
| NO (1) | NO175216C (de) |
| NZ (1) | NZ215920A (de) |
| PT (1) | PT82429B (de) |
Families Citing this family (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58149871A (ja) * | 1982-02-27 | 1983-09-06 | 本田技研工業株式会社 | 二，三輪車の盗難防止装置 |
| JPS6087751A (ja) * | 1983-10-20 | 1985-05-17 | House Food Ind Co Ltd | レトルト豆腐の製造法 |
| EP0201153A3 (de) * | 1985-02-09 | 1987-10-07 | Beecham Group Plc | Modifiziertes Enzym und Verfahren zu dessen Herstellung |
| WO1986005096A1 (en) * | 1985-03-06 | 1986-09-12 | Survival Technology, Inc. | Protein absorption enhancing agents |
| HU206520B (en) * | 1985-04-22 | 1992-11-30 | Genentech Inc | Process for producing new human tissue plasminogen activator /tpa/ mutants and pharmaceutical compositions containing them |
| WO1993012225A1 (en) * | 1991-12-16 | 1993-06-24 | Genentech, Inc. | Novel tissue plasminogen activator variants |
| US5736134A (en) * | 1985-04-22 | 1998-04-07 | Genentech, In.C | Tissue plasminogen activator variants |
| US5756093A (en) * | 1985-04-22 | 1998-05-26 | Genentech, Inc. | Tissue plasminogen activator variants |
| US4959318A (en) * | 1985-06-27 | 1990-09-25 | Zymogenetics, Inc. | Expression of protein C |
| US4777043A (en) * | 1985-12-17 | 1988-10-11 | Genentech, Inc. | Stabilized human tissue plasminogen activator compositions |
| ZA869626B (en) * | 1985-12-23 | 1987-10-28 | Chiron Corp | Peptide plasminogen activators |
| DK43387A (da) * | 1986-01-29 | 1987-07-30 | Beecham Group Plc | Fibrinolytisk enzym |
| US5837518A (en) * | 1986-01-31 | 1998-11-17 | Genetics Institute, Inc. | Thrombolytic proteins |
| US5258298A (en) * | 1986-01-31 | 1993-11-02 | Genetics Institute, Inc. | Deletion and glycosylation mutant of human tissue plasminogen activator |
| US5071972A (en) * | 1986-01-31 | 1991-12-10 | Genetics Institute, Inc. | DNA sequences encoding novel thrombolytic proteins |
| DE3789664T3 (de) * | 1986-01-31 | 2004-09-16 | Genetics Institute, LLC, Cambridge | Neue thrombolytische proteine. |
| IE81073B1 (en) * | 1986-03-18 | 2000-01-12 | Genentech Inc | Modified human tissue-type plasminogen activator and its preparation |
| US5589361A (en) * | 1986-03-18 | 1996-12-31 | Genentech, Inc. | Human tissue-type plasminogen activator variant |
| PT84588B (en) * | 1986-04-02 | 1989-05-09 | Beecham Group Plc | Process for preparing a fibrinolytic enzyme |
| PT84589B (en) * | 1986-04-02 | 1989-05-09 | Beecham Group Plc | Process for preparing a fibrinolytic enzyme |
| US5169763A (en) * | 1986-04-08 | 1992-12-08 | Transgene S.A., Institut Pasteur | Viral vector coding glycoprotein of HIV-1 |
| GB8701811D0 (en) * | 1987-01-28 | 1987-03-04 | Beecham Group Plc | Compounds |
| MY103358A (en) * | 1987-04-15 | 1993-06-30 | Novartis Ag | Process for the production of protiens. |
| DK275788A (da) * | 1987-05-22 | 1989-02-03 | Zymogenetics Inc | Fibrinolytiske proteiner |
| US5200340A (en) * | 1987-05-22 | 1993-04-06 | Zymogenetics, Inc. | Thrombin-activated tissue plasminogen activators |
| ATE110772T1 (de) * | 1987-06-04 | 1994-09-15 | Zymogenetics Inc | Mutierter t-pa mit kringle-ersatz. |
| EP0293936B1 (de) * | 1987-06-04 | 1995-02-22 | Zymogenetics, Inc. | Gewebs-Plasminogen-Aktivator-Analoge mit modifizierten Wachstumsfaktordomänen |
| DE3886755T3 (de) * | 1987-06-30 | 2005-12-08 | Genentech, Inc., South San Francisco | Verfahren zur behandlung von gefässkrankheiten. |
| US5302390A (en) * | 1987-07-01 | 1994-04-12 | Beecham Group Plc | Hybrid proteins of human plasminogen and human t-PA, pharmaceutical compositions and methods of treatment |
| IL87276A (en) * | 1987-08-03 | 1995-07-31 | Fujisawa Pharmaceutical Co | Analog of tissue plasminogen activator comprising only the kringle 2 and protease domain dna encoding the same processes for the preparation thereof and pharmaceutical compositions containing the same |
| JP2708749B2 (ja) * | 1987-08-10 | 1998-02-04 | エーザイ株式会社 | 修飾型ｔＰＡ含有注射用組成物 |
| US5037752A (en) * | 1987-10-09 | 1991-08-06 | Monsanto Company | Modified tissue plasminogen activator substituted at cysteine-73 and lysine-277 |
| US4963357A (en) * | 1987-10-09 | 1990-10-16 | Monsanto Company | Tissue plasminogen activator modified by the substitution of Arg for Cys at position 73, methods and pharmaceutical compositions therefor |
| US5244676A (en) * | 1987-10-09 | 1993-09-14 | Monsanto Company | Modified tissue plasminogen activator with modified glycosylation site |
| EP0312346B1 (de) * | 1987-10-16 | 1994-08-17 | Genencor International, Inc. | Sequenzspezifische saure E.coli-Protease |
| KR970005046B1 (ko) * | 1987-10-29 | 1997-04-11 | 야마노우찌 세이야꾸 가부시끼가이샤 | 개량형 조직 플라스미노겐 활성화 인자 |
| US5504001A (en) * | 1987-11-25 | 1996-04-02 | Zymogenetics, Inc. | Hybrid plasminogen activator |
| US5094953A (en) * | 1988-03-21 | 1992-03-10 | Genentech, Inc. | Human tissue plasminogen activator variants |
| AU4216689A (en) * | 1988-08-11 | 1990-03-05 | California Biotechnology, Inc. | Method for stabilizing heterologous protein expression and vectors for use therein |
| US5262170A (en) * | 1988-09-02 | 1993-11-16 | Genentech, Inc. | Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells |
| US5108901A (en) * | 1988-09-02 | 1992-04-28 | Genentech, Inc. | Tissue plasminogen activator having zymogenic or fibrin specific properties |
| US5258180A (en) * | 1988-09-02 | 1993-11-02 | Genetech, Inc. | Tissue plasminogen activator having fibrin specific properties and deletion of amino acids 466-970, compositions and methods of treatment |
| US5714145A (en) * | 1988-09-02 | 1998-02-03 | Genentech, Inc. | Tissue plasminogen activator having zymogenic or fibrin specific properties |
| US5190756A (en) * | 1989-12-01 | 1993-03-02 | Genentech, Inc. | Methods and materials for expression of human plasminogen variant |
| US5087572A (en) * | 1989-12-01 | 1992-02-11 | Genentech, Inc. | Dna encoding human plasminogen modified at the cleavage site |
| DE3942142A1 (de) * | 1989-12-20 | 1991-06-27 | Boehringer Mannheim Gmbh | Stabilisierung von glykosyliertem t-pa |
| CA2124937C (en) * | 1991-12-16 | 2001-06-05 | William F. Bennett | T-pa substitution variants with improved fibrin-specificity |
| AU664469B2 (en) * | 1992-06-03 | 1995-11-16 | Genentech Inc. | Tissue plasminogen activator glycosylation variants with improved therapeutic properties |
| GB2298821A (en) * | 1995-03-15 | 1996-09-18 | Prestek Ltd | A ribbon winding mechanism |
| EP0827751B1 (de) * | 1996-09-06 | 2003-02-26 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Medizinische Zusammensetzung die Gewebeplasminogenaktivator und Nikotinamid enthält |
| US6706504B1 (en) | 1996-11-12 | 2004-03-16 | The Scripps Research Institute | Tissue type plasminogen activator (t-PA) variants: compositions and methods of use |
| AU735519B2 (en) * | 1996-11-12 | 2001-07-12 | Scripps Research Institute, The | Tissue type plasminogen activator (t-PA) variants: compositions and methods of use |
| US5837688A (en) * | 1996-11-27 | 1998-11-17 | Gelfand; Mathew I. | Use of thrombolytic reagents for prevention of vascular disease |
| WO2002020802A1 (en) | 2000-09-04 | 2002-03-14 | Hunan Royal Biotech | A cell line expressing mutant human tissue-type plasminogen activator, constructing strategy and method of expressed protein preparation |
| US7597895B2 (en) * | 2001-02-20 | 2009-10-06 | The Governing Council Of The University Of Toronto | Signal peptides, nucleic acid molecules and methods for treatment of caries |
| US7556807B2 (en) | 2001-02-20 | 2009-07-07 | Kane Biotech, Inc. | Signal peptides, nucleic acid molecules and methods for treatment of caries |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR241654A1 (es) * | 1982-05-05 | 1992-10-30 | Genentech Inc | Procedimiento para producir activador de plasminogeno de tejido humano. |
| KR840004781A (ko) * | 1982-05-05 | 1984-10-24 | 월터 에이치·드레거 | 인체의 조직 플라스미노겐 활성화제 |
| IL90047A (en) * | 1982-10-19 | 1992-12-01 | Cetus Oncology Corp | Cysteine-depleted biologically active muteins other than interferon - ' |
| US4753879A (en) * | 1984-08-27 | 1988-06-28 | Biogen N.V. | Modified tissue plasminogen activators |
| EP0201153A3 (de) * | 1985-02-09 | 1987-10-07 | Beecham Group Plc | Modifiziertes Enzym und Verfahren zu dessen Herstellung |
| HU206520B (en) * | 1985-04-22 | 1992-11-30 | Genentech Inc | Process for producing new human tissue plasminogen activator /tpa/ mutants and pharmaceutical compositions containing them |
| DK43387A (da) * | 1986-01-29 | 1987-07-30 | Beecham Group Plc | Fibrinolytisk enzym |
| DE3789664T3 (de) * | 1986-01-31 | 2004-09-16 | Genetics Institute, LLC, Cambridge | Neue thrombolytische proteine. |
-
1986
- 1986-04-21 HU HU861676A patent/HU206520B/hu unknown
- 1986-04-21 AT AT86302980T patent/ATE68825T1/de not_active IP Right Cessation
- 1986-04-21 GR GR861037A patent/GR861037B/el unknown
- 1986-04-21 DD DD28944386A patent/DD258026A5/de unknown
- 1986-04-21 FI FI861673A patent/FI98930C/fi not_active IP Right Cessation
- 1986-04-21 GB GB8609683A patent/GB2173804B/en not_active Expired
- 1986-04-21 EP EP86302980A patent/EP0199574B1/de not_active Expired - Lifetime
- 1986-04-21 DK DK198601812A patent/DK175380B1/da not_active IP Right Cessation
- 1986-04-21 DE DE8686302980T patent/DE3682104D1/de not_active Expired - Lifetime
- 1986-04-21 AU AU56416/86A patent/AU596356B2/en not_active Expired
- 1986-04-21 PT PT82429A patent/PT82429B/pt unknown
- 1986-04-21 FR FR868605756A patent/FR2581652B1/fr not_active Expired
- 1986-04-21 DE DE3613390A patent/DE3613390C2/de not_active Expired - Lifetime
- 1986-04-21 IL IL78571A patent/IL78571A/xx not_active IP Right Cessation
- 1986-04-21 IE IE105586A patent/IE58574B1/en not_active IP Right Cessation
- 1986-04-21 NO NO861559A patent/NO175216C/no unknown
- 1986-04-22 ES ES554251A patent/ES8802184A1/es not_active Expired
- 1986-04-22 JP JP61094382A patent/JPH0740940B2/ja not_active Expired - Lifetime
- 1986-04-22 NZ NZ215920A patent/NZ215920A/xx unknown
- 1986-04-22 CA CA000507294A patent/CA1341580C/en not_active Expired - Fee Related
-
1987
- 1987-09-21 MY MYPI87001800A patent/MY102550A/en unknown
-
1988
- 1988-01-15 ES ES557800A patent/ES9000011A1/es not_active Expired
-
1991
- 1991-08-05 US US07/741,120 patent/US5147643A/en not_active Expired - Lifetime
-
1994
- 1994-02-16 JP JP6019382A patent/JP2529816B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL78571A (en) | Human tissue plasminogen activator mutants resistant to enzymatic cleavage resulting in two-chain form | |
| EP0370036B1 (de) | Modifizierter faktor vii/viia | |
| EP0213794A1 (de) | Poly-Kringle-Plasminogenaktivator | |
| AU572108B2 (en) | Human tpa production using vectors coding for dhfr protein | |
| ES8205263A1 (es) | Un procedimiento para la produccion de una proteina activadora del piasminogeno. | |
| HUT56884A (en) | Process for producing protein having urate oxidase activity, gene coding for it, expression vector, microorganisms and transformed cells | |
| US5338546A (en) | Tissue plasminogen activator variants with decreased clearance | |
| DE3886755T2 (de) | Verfahren zur behandlung von gefässkrankheiten. | |
| US5714372A (en) | Tissue plasminogen activator variants | |
| WO1998021320A9 (en) | TISSUE TYPE PLASMINOGEN ACTIVATOR (t-PA) VARIANTS: COMPOSITIONS AND METHODS OF USE | |
| US6706504B1 (en) | Tissue type plasminogen activator (t-PA) variants: compositions and methods of use | |
| AU5585098A (en) | Tissue type plasminogen activator (t-pa) variants: compositions and methods of use | |
| DE69105121T2 (de) | Gewebeplasminogenaktivator mit fibrin-spezifischen eigenschaften. | |
| EP0542869B1 (de) | Varianten des gewebeplasminogenaktivators mit vermindertem abbau | |
| AU649765B2 (en) | Tissue plasminogen activator substitution variant | |
| US5756093A (en) | Tissue plasminogen activator variants |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| EXP | Patent expired |